On the public citation graph
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
0 signed · 203 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pmic.201000472openalex-snapshot
Improved Phos‐tag SDS‐PAGE under neutral pH conditions for advanced protein phosphorylation profiling
inferredcites →https://doi.org/10.1002/stem.1128openalex-snapshot
Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers
inferredcites →https://doi.org/10.1007/s13277-010-0060-6openalex-snapshot
Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma
inferredcites →https://doi.org/10.1016/j.biocel.2008.07.019openalex-snapshot
Eph/ephrin signaling in epithelial development and homeostasis
inferredcites →https://doi.org/10.1016/j.ccr.2009.04.009openalex-snapshot
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
inferredcites →https://doi.org/10.1016/j.ccr.2012.11.005openalex-snapshot
The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas
inferredcites →https://doi.org/10.1016/j.cell.2009.12.040openalex-snapshot
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
inferredcites →https://doi.org/10.1016/j.cell.2010.06.011openalex-snapshot
Cell Signaling by Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1016/j.cllc.2011.09.004openalex-snapshot
Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)
inferredcites →https://doi.org/10.1016/j.critrevonc.2003.08.004openalex-snapshot
Tyrosine kinase receptors as attractive targets of cancer therapy
inferredcites →https://doi.org/10.1016/j.ctrv.2014.08.003openalex-snapshot
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis
inferredcites →https://doi.org/10.1016/j.fob.2013.01.002openalex-snapshot
Ephexin4‐mediated promotion of cell migration and anoikis resistance is regulated by serine 897 phosphorylation of EphA2
inferredcites →https://doi.org/10.1016/j.molcel.2009.04.034openalex-snapshot
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
inferredcites →https://doi.org/10.1016/j.molcel.2009.08.002openalex-snapshot
RSK Is a Principal Effector of the RAS-ERK Pathway for Eliciting a Coordinate Promotile/Invasive Gene Program and Phenotype in Epithelial Cells
inferredcites →https://doi.org/10.1016/j.mrrev.2004.02.001openalex-snapshot
Genotoxicity of tobacco smoke and tobacco smoke condensate: a review
inferredcites →https://doi.org/10.1016/j.semcdb.2011.10.013openalex-snapshot
EphA receptor signaling—Complexity and emerging themes
inferredcites →https://doi.org/10.1016/j.tips.2012.06.007openalex-snapshot
Targeting of TAK1 in inflammatory disorders and cancer
inferredcites →https://doi.org/10.1016/j.yexcr.2011.05.014openalex-snapshot
Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase
inferredcites →https://doi.org/10.1016/s0006-291x(02)00806-9openalex-snapshot
Negative regulation of EphA2 receptor by Cbl
inferredcites →https://doi.org/10.1016/s0092-8674(00)00114-8openalex-snapshot
Cell Signaling by Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1038/nature08902openalex-snapshot
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
inferredcites →https://doi.org/10.1038/onc.2011.210openalex-snapshot
Epha2 is a critical oncogene in melanoma
inferredcites →https://doi.org/10.1038/onc.2013.238openalex-snapshot
EphA2 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells
inferredcites →https://doi.org/10.1038/onc.2013.425openalex-snapshot
RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789
inferredcites →https://doi.org/10.1038/onc.2013.590openalex-snapshot
EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties
inferredcites →https://doi.org/10.1038/sj.emboj.7600128openalex-snapshot
Tiam1 mediates neurite outgrowth induced by ephrin‐B1 and EphA2
inferredcites →https://doi.org/10.1042/bj20061088openalex-snapshot
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo
inferredcites →https://doi.org/10.1056/nejmoa1203421openalex-snapshot
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1406037openalex-snapshot
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
inferredcites →https://doi.org/10.1074/jbc.m005497200openalex-snapshot
Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKB
inferredcites →https://doi.org/10.1074/jbc.m112.421669openalex-snapshot
Phosphorylation of Serine 779 in Fibroblast Growth Factor Receptor 1 and 2 by Protein Kinase Cϵ Regulates Ras/Mitogen-activated Protein Kinase Signaling and Neuronal Differentiation
inferredcites →https://doi.org/10.1074/jbc.m112.423046openalex-snapshot
RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration
inferredcites →https://doi.org/10.1074/jbc.m608723200openalex-snapshot
Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-α through the TAK1-p38 Signaling Pathway
inferredcites →https://doi.org/10.1083/jcb.201005141openalex-snapshot
Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism
inferredcites →https://doi.org/10.1091/mbc.e11-10-0883openalex-snapshot
P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
inferredcites →https://doi.org/10.1093/nar/gkr1122openalex-snapshot
PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse
inferredcites →https://doi.org/10.1111/cas.12225openalex-snapshot
Inverse correlation between T hr‐669 and constitutive tyrosine phosphorylation in the asymmetric epidermal growth factor receptor dimer conformation
inferredcites →https://doi.org/10.1126/scisignal.2003087openalex-snapshot
ERK-Mediated Phosphorylation of Fibroblast Growth Factor Receptor 1 on Ser 777 Inhibits Signaling
inferredcites →https://doi.org/10.1128/mcb.00375-09openalex-snapshot
TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-κB-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling
inferredcites →https://doi.org/10.1128/mcb.24.7.3025-3035.2004openalex-snapshot
Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site
inferredcites →https://doi.org/10.1128/mmbr.00031-10openalex-snapshot
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
inferredcites →https://doi.org/10.1158/0008-5472.can-12-4448openalex-snapshot
The p90 RSK Family Members: Common Functions and Isoform Specificity
inferredcites →https://doi.org/10.1158/0008-5472.can-13-1087openalex-snapshot
RSK Isoforms in Cancer Cell Invasion and Metastasis
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-0473openalex-snapshot
Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-07-0148openalex-snapshot
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
inferredcites →https://doi.org/10.1158/1535-7163.mct-10-0799openalex-snapshot
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
inferredcites →https://doi.org/10.1158/1940-6207.capr-09-0212openalex-snapshot
EphA2 in the Early Pathogenesis and Progression of Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1158/2159-8290.cd-14-0293openalex-snapshot
Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype
inferredcites →https://doi.org/10.1158/2159-8290.cd-14-0295openalex-snapshot
EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
inferredcites →https://doi.org/10.1172/jci33154openalex-snapshot
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
inferredcites →https://doi.org/10.1172/jci72522openalex-snapshot
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
inferredcites →https://doi.org/10.1517/14728222.2011.538682openalex-snapshot
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
inferredcites →https://doi.org/10.3389/fonc.2013.00201openalex-snapshot
A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer
inferredcites →https://doi.org/10.3892/or_00000670openalex-snapshot
EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma
inferredcites →https://doi.org/10.3892/or_00001020openalex-snapshot
Expression of EphA1 in gastric carcinomas is associated with metastasis and survival
inferredcites →https://doi.org/10.5167/uzh-63198openalex-snapshot
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5022615openalex-extracted
An Anti-Human Epha2 Monoclonal Antibody Ea2mab-7 Shows High Sensitivity for Flow Cytometry, Western Blot, and Immunohistochemical Analyses
inferred← citeshttps://doi.org/10.1002/cbdv.201900315openalex-snapshot
Design and Construction of Aroyl‐Hydrazone Derivatives: Synthesis, Crystal Structure, Molecular Docking and Their Biological Activities
inferred← citeshttps://doi.org/10.1002/cpps.64openalex-snapshot
Analysis of Protein Phosphorylation Using Phos‐Tag Gels
inferred← citeshttps://doi.org/10.1002/ijc.31405openalex-snapshot
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
inferred← citeshttps://doi.org/10.1002/ijc.32609openalex-snapshot
EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
inferred← citeshttps://doi.org/10.1007/82_2025_333openalex-snapshot
Akt/PKB Functions in Cell Migration and Invasion
inferred← citeshttps://doi.org/10.1007/978-1-4614-6438-9_101649-1openalex-snapshot
Ephrin Receptor A2
inferred← citeshttps://doi.org/10.1007/s00109-024-02431-xopenalex-snapshot
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
inferred← citeshttps://doi.org/10.1007/s10549-019-05482-8openalex-snapshot
Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast
inferred← citeshttps://doi.org/10.1007/s10930-025-10293-6openalex-snapshot
Unravelling the Phosphorylation Landscape of Anthrax Toxin Receptor 1: Mechanisms and Functional Insights Through Phosphoproteomic Data Integration
inferred← citeshttps://doi.org/10.1007/s11033-020-05767-yopenalex-snapshot
The EphA2 and cancer connection: potential for immune-based interventions
inferred← citeshttps://doi.org/10.1007/s11033-026-12252-5openalex-snapshot
EphA2 as an oncogenic driver: roles and mechanisms of action in cancer
inferred← citeshttps://doi.org/10.1007/s12672-024-01380-8openalex-snapshot
Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review
inferred← citeshttps://doi.org/10.1007/s13402-020-00511-xopenalex-snapshot
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2025.120081openalex-snapshot
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2025.120098openalex-snapshot
Ephrin-A1/EphA2 modulates vascular smooth muscle cell proliferation in vitro, while VSMC-specific ephrin-A1 deletion is not sufficient to alter arteriosclerosis in vivo
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2026.120196openalex-snapshot
FGFR1 induces RSK-dependent non-canonical activation of EphA2 during EMT
inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.04.020openalex-snapshot
Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.12.002openalex-snapshot
EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates
inferred← citeshttps://doi.org/10.1016/j.bbrc.2019.04.125openalex-snapshot
Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.01.050openalex-snapshot
Filamin A forms a complex with EphA2 and regulates EphA2 serine 897 phosphorylation and glioblastoma cell proliferation
inferred← citeshttps://doi.org/10.1016/j.bbrep.2018.08.004openalex-snapshot
Discovery of a sugar-based nanoparticle universally existing in boiling herbal water extracts and their immunostimulant effect
inferred← citeshttps://doi.org/10.1016/j.bbrep.2025.101960openalex-snapshot
Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry
inferred← citeshttps://doi.org/10.1016/j.bbrep.2025.101998openalex-snapshot
Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.07.030openalex-snapshot
Viewing the Eph receptors with a focus on breast cancer heterogeneity
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.12.011openalex-snapshot
S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.02.019openalex-snapshot
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2
inferred← citeshttps://doi.org/10.1016/j.cellsig.2016.04.009openalex-snapshot
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
inferred← citeshttps://doi.org/10.1016/j.cellsig.2020.109668openalex-snapshot
Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains
inferred← citeshttps://doi.org/10.1016/j.cellsig.2022.110579openalex-snapshot
Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers
inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107568openalex-snapshot
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC
inferred← citeshttps://doi.org/10.1016/j.cub.2021.03.094openalex-snapshot
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas
inferred← citeshttps://doi.org/10.1016/j.devcel.2020.05.031openalex-snapshot
Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.10.026openalex-snapshot
Design and synthesis of small molecule agonists of EphA2 receptor
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115229openalex-snapshot
RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges
inferred← citeshttps://doi.org/10.1016/j.exer.2017.06.016openalex-snapshot
EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e40871openalex-snapshot
A multi-model approach identifies ALW-II-41-27 as a promising therapy for osteoarthritis-associated inflammation and endochondral ossification
inferred← citeshttps://doi.org/10.1016/j.isci.2020.101692openalex-snapshot
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas
inferred← citeshttps://doi.org/10.1016/j.isci.2025.111872openalex-snapshot
Perturbation of EPHA2 and EFNA1 trans binding amplifies inflammatory response in airway epithelial cells
inferred← citeshttps://doi.org/10.1016/j.jbc.2023.104699openalex-snapshot
Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway
inferred← citeshttps://doi.org/10.1016/j.jbc.2024.108099openalex-snapshot
Missense mutations of the ephrin receptor EPHA1 associated with Alzheimer’s disease disrupt receptor signaling functions
inferred← citeshttps://doi.org/10.1016/j.jbc.2026.111271openalex-snapshot
Targeting EphA2 under DNA damage causes mitotic bypass via p21 induction
inferred← citeshttps://doi.org/10.1016/j.jbc.2026.113301openalex-snapshot
EGFR endocytosis down-regulates binding to EphA2 at the plasma membrane
inferred← citeshttps://doi.org/10.1016/j.jgg.2021.02.011openalex-snapshot
EphA2: A promising therapeutic target in breast cancer
inferred← citeshttps://doi.org/10.1016/j.jmb.2019.01.038openalex-snapshot
Rewiring of RSK–PDZ Interactome by Linear Motif Phosphorylation
inferred← citeshttps://doi.org/10.1016/j.matbio.2020.03.009openalex-snapshot
Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer
inferred← citeshttps://doi.org/10.1016/j.matbio.2021.09.001openalex-snapshot
EphA2 signaling within integrin adhesions regulates fibrillar adhesion elongation and fibronectin deposition
inferred← citeshttps://doi.org/10.1016/j.neo.2018.04.006openalex-snapshot
Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab
inferred← citeshttps://doi.org/10.1016/j.prp.2021.153642openalex-snapshot
High RSK4 expression constitutes a predictor of poor prognosis for patients with clear cell renal carcinoma
inferred← citeshttps://doi.org/10.1016/j.rvsc.2017.06.001openalex-snapshot
Serum microRNAs in buffalo cows: Potential biomarkers of pregnancy
inferred← citeshttps://doi.org/10.1016/j.tibs.2024.10.002openalex-snapshot
Eph receptor signaling complexes in the plasma membrane
inferred← citeshttps://doi.org/10.1016/j.yexcr.2020.112207openalex-snapshot
Kinase activity-independent role of EphA2 in the regulation of M-phase progression
inferred← citeshttps://doi.org/10.1016/j.yexcr.2026.114898openalex-snapshot
Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion
inferred← citeshttps://doi.org/10.1038/cddis.2017.406openalex-snapshot
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
inferred← citeshttps://doi.org/10.1038/s41388-021-01714-8openalex-snapshot
Oncogenic functions and therapeutic targeting of EphA2 in cancer
inferred← citeshttps://doi.org/10.1038/s41388-021-01786-6openalex-snapshot
EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
inferred← citeshttps://doi.org/10.1038/s41416-025-03131-0openalex-snapshot
LMP2A regulates S901 phosphorylation of EphA2 to maintain EBV latent infection in gastric cancer
inferred← citeshttps://doi.org/10.1038/s41418-017-0055-6openalex-snapshot
β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer
inferred← citeshttps://doi.org/10.1038/s41419-020-02831-0openalex-snapshot
Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway
inferred← citeshttps://doi.org/10.1038/s41419-020-2521-1openalex-snapshot
HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis
inferred← citeshttps://doi.org/10.1038/s41419-023-06188-yopenalex-snapshot
Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers
inferred← citeshttps://doi.org/10.1038/s41467-020-15173-4openalex-snapshot
Phosphoproteomics identifies a bimodal EPHA2 receptor switch that promotes embryonic stem cell differentiation
inferred← citeshttps://doi.org/10.1038/s41467-021-26839-yopenalex-snapshot
Nuclear-capture of endosomes depletes nuclear G-actin to promote SRF/MRTF activation and cancer cell invasion
inferred← citeshttps://doi.org/10.1038/s41467-021-27343-zopenalex-snapshot
Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker
inferred← citeshttps://doi.org/10.1038/s41568-023-00634-xopenalex-snapshot
Eph receptors and ephrins in cancer progression
inferred← citeshttps://doi.org/10.1038/s41598-024-52020-8openalex-snapshot
Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia
inferred← citeshttps://doi.org/10.1038/s41598-025-20770-8openalex-snapshot
Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway
inferred← citeshttps://doi.org/10.1038/s42003-018-0017-7openalex-snapshot
The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures
inferred← citeshttps://doi.org/10.1038/srep31502openalex-snapshot
Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain
inferred← citeshttps://doi.org/10.1042/bst20201074openalex-snapshot
Single-molecule fluorescence vistas of how lipids regulate membrane proteins
inferred← citeshttps://doi.org/10.1073/pnas.1719961115openalex-snapshot
Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility
inferred← citeshttps://doi.org/10.1074/jbc.m117.811299openalex-snapshot
Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation
inferred← citeshttps://doi.org/10.1074/jbc.ra119.007431openalex-snapshot
p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration
inferred← citeshttps://doi.org/10.1074/jbc.ra120.016423openalex-snapshot
PIP2 promotes conformation-specific dimerization of the EphA2 membrane region
inferred← citeshttps://doi.org/10.1074/mcp.ra119.001811openalex-snapshot
Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion
inferred← citeshttps://doi.org/10.1080/07391102.2022.2064915openalex-snapshot
Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study
inferred← citeshttps://doi.org/10.1080/09553002.2017.1355580openalex-snapshot
Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent manner
inferred← citeshttps://doi.org/10.1080/13543776.2016.1212839openalex-snapshot
Ribosomal S6 kinase (RSK) modulators: a patent review
inferred← citeshttps://doi.org/10.1080/14728222.2024.2433123openalex-snapshot
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
inferred← citeshttps://doi.org/10.1080/14728222.2025.2500422openalex-snapshot
Cataract-related mutations in EphA2: a survey of literature data and the relevance of the receptor Sam domain
inferred← citeshttps://doi.org/10.1083/jcb.202507217openalex-snapshot
EPHA2/CD44-directed trafficking enhances endosomal leakiness and antisense therapy delivery
inferred← citeshttps://doi.org/10.1089/thy.2019.0728openalex-snapshot
Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells
inferred← citeshttps://doi.org/10.1091/mbc.e16-01-0048openalex-snapshot
Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
inferred← citeshttps://doi.org/10.1093/jb/mvx048openalex-snapshot
ERK signalling as a regulator of cell motility
inferred← citeshttps://doi.org/10.1093/neuonc/noy046openalex-snapshot
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
inferred← citeshttps://doi.org/10.1096/fj.201801519rropenalex-snapshot
EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ ERK/RSK pathway regulates M‐phase progression via maintenance of cortical rigidity
inferred← citeshttps://doi.org/10.1101/2020.04.09.034405openalex-snapshot
The Ephrin receptor A2 and Roundabout Guidance Receptor 1 heterodimer: A potential theranostic for squamous cell carcinomas
inferred← citeshttps://doi.org/10.1101/2020.09.14.295394openalex-snapshot
Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancer
inferred← citeshttps://doi.org/10.1101/2025.01.03.631197openalex-snapshot
EPHA2-Ephrin-B1 cis -interaction supports self-renewal ability leading to recurrence of oral cancer
inferred← citeshttps://doi.org/10.1101/2025.02.05.635637openalex-snapshot
EPHA2 and scavenger receptor-directed trafficking enhances endosomal leakiness and antisense therapy delivery
inferred← citeshttps://doi.org/10.1101/419721openalex-snapshot
Rewiring of RSK-PDZ interactions by linear motif phosphorylation
inferred← citeshttps://doi.org/10.1111/1346-8138.15969openalex-snapshot
Successful rechallenge therapy for BRAF/MEK inhibitor‐resistant multiple brain metastases of melanoma
inferred← citeshttps://doi.org/10.1111/cas.15638openalex-snapshot
Proteolytic cleavage of membrane proteins by membrane type‐1 MMP regulates cancer malignant progression
inferred← citeshttps://doi.org/10.1111/cas.15653openalex-snapshot
Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1 ‐mediated SOX2 methylation
inferred← citeshttps://doi.org/10.1111/cas.70173openalex-snapshot
SOX10 Regulates Melanoma Metastasis Through the IRF1 ‐ ITGA3 / EphA2 ‐ FAK Pathway
inferred← citeshttps://doi.org/10.1111/cas.70291openalex-snapshot
A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma
inferred← citeshttps://doi.org/10.1111/jcmm.16337openalex-snapshot
EphA2 promotes tumorigenicity of cervical cancer by up‐regulating CDK6
inferred← citeshttps://doi.org/10.1111/jnc.70110openalex-snapshot
Multi‐Omic Analysis of Glutamate Excitotoxicity in Primary Neuronal Cultures
inferred← citeshttps://doi.org/10.1126/scisignal.aau1207openalex-snapshot
Caught in the “Akt”: Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF
inferred← citeshttps://doi.org/10.1126/scisignal.abd9943openalex-snapshot
Growth factor–dependent ErbB vesicular dynamics couple receptor signaling to spatially and functionally distinct Erk pools
inferred← citeshttps://doi.org/10.1126/scitranslmed.adg5768openalex-snapshot
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis
inferred← citeshttps://doi.org/10.1158/0008-5472.can-15-0717openalex-snapshot
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
inferred← citeshttps://doi.org/10.1158/0008-5472.can-17-2063openalex-snapshot
ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis
inferred← citeshttps://doi.org/10.1158/0008-5472.can-20-0560openalex-snapshot
ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-16-0106openalex-snapshot
Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1172/jci134930openalex-snapshot
Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1186/s12935-025-03826-7openalex-snapshot
EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK
inferred← citeshttps://doi.org/10.1186/s12964-025-02441-3openalex-snapshot
Crosstalk between tumor endothelial cells and cancer cells is important for metastasis initiation
inferred← citeshttps://doi.org/10.1186/s12964-026-02788-1openalex-snapshot
EPHA2-Ephrin-B1 cis-interaction drives an oncogenic reverse signaling, leading to the recurrence of oral cancer
inferred← citeshttps://doi.org/10.1186/s13046-022-02546-4openalex-snapshot
Complexity of progranulin mechanisms of action in mesothelioma
inferred← citeshttps://doi.org/10.1248/bpb.b17-00446openalex-snapshot
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression
inferred← citeshttps://doi.org/10.1248/bpb.b21-00371openalex-snapshot
Temozolomide Induces Endocytosis of EGFRvIII via p38-Mediated Non-canonical Phosphorylation in Glioblastoma Cells
inferred← citeshttps://doi.org/10.1248/bpb.b21-00567openalex-snapshot
RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen
inferred← citeshttps://doi.org/10.1248/bpb.b24-00747openalex-snapshot
Stress Response Kinase MK2 Induces Non-canonical Activation of EphA2 in EML4-ALK Lung Cancer Cells
inferred← citeshttps://doi.org/10.1248/bpb.b25-00324openalex-snapshot
Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions
inferred← citeshttps://doi.org/10.1248/yakushi.16-00229-4openalex-snapshot
Non-canonical Activation of Receptor Tyrosine Kinases in Cancer Progression
inferred← citeshttps://doi.org/10.1371/journal.ppat.1006580openalex-snapshot
Male hormones activate EphA2 to facilitate Kaposi’s sarcoma-associated herpesvirus infection: Implications for gender disparity in Kaposi’s sarcoma
inferred← citeshttps://doi.org/10.15252/emmm.201911177openalex-snapshot
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
inferred← citeshttps://doi.org/10.1530/jme-16-0216openalex-snapshot
RSK activation via ERK modulates human colon cancer cells response to PTHrP
inferred← citeshttps://doi.org/10.1620/tjem.238.143openalex-snapshot
MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2
inferred← citeshttps://doi.org/10.17219/acem/156673openalex-snapshot
Silencing of TMED5 inhibits proliferation, migration and invasion, and enhances apoptosis of hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.18632/aging.206144openalex-snapshot
Canonical ligand-dependent and non-canonical ligand-independent EphA2 signaling in the eye lens of wild-type, knockout, and aging mice
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2572171/v1openalex-snapshot
Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia
inferred← citeshttps://doi.org/10.22038/ijbms.2016.7466openalex-snapshot
miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2.
inferred← citeshttps://doi.org/10.2217/imt-2016-0076openalex-snapshot
Adoptive Immunotherapy for the Treatment of Glioblastoma: Progress and Possibilities
inferred← citeshttps://doi.org/10.3389/fcell.2022.852236openalex-snapshot
Roles of Eph-Ephrin Signaling in the Eye Lens Cataractogenesis, Biomechanics, and Homeostasis
inferred← citeshttps://doi.org/10.3389/fonc.2023.1117326openalex-snapshot
The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration
inferred← citeshttps://doi.org/10.3389/fphar.2023.1086813openalex-snapshot
Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
inferred← citeshttps://doi.org/10.3390/cancers13040700openalex-snapshot
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
inferred← citeshttps://doi.org/10.3390/cancers13051010openalex-snapshot
EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
inferred← citeshttps://doi.org/10.3390/cancers15061706openalex-snapshot
Progranulin Oncogenic Network in Solid Tumors
inferred← citeshttps://doi.org/10.3390/cells10112893openalex-snapshot
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma
inferred← citeshttps://doi.org/10.3390/ijms23116127openalex-snapshot
Adaptation and Changes in Actin Dynamics and Cell Motility as Early Responses of Cultured Mammalian Cells to Altered Gravitational Vector
inferred← citeshttps://doi.org/10.3390/ijms231810397openalex-snapshot
Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions
inferred← citeshttps://doi.org/10.3390/ijms27073221openalex-snapshot
Antitumor Activities of Chimeric Anti-EphA2 Antibodies in Xenograft Models of Breast, Pancreatic, and Colorectal Cancers
inferred← citeshttps://doi.org/10.3410/f.738181995.793577959openalex-snapshot
Faculty Opinions recommendation of Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex.
inferred← citeshttps://doi.org/10.3892/ijo.2019.4717openalex-snapshot
Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway
inferred← citeshttps://doi.org/10.3892/ijo.2020.5119openalex-snapshot
ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation
inferred← citeshttps://doi.org/10.3892/ol.2018.8485openalex-snapshot
Cisplatin‑induced non‑canonical endocytosis of EGFR via p38 phosphorylation of the C‑terminal region containing Ser‑1015 in non‑small cell lung cancer cells
inferred← citeshttps://doi.org/10.3892/ol.2020.11760openalex-snapshot
ERK‑mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells
inferred← citeshttps://doi.org/10.70675/47d0433az4375z4bc8za315z0be93e98d476openalex-snapshot
Plasticité des réseaux de récepteurs membranaires dans la signalisation du NGF et de son précurseur dans les cancers du sein
inferred← citeshttps://doi.org/10.70675/a74ac96dz6027z4fa1z8788z06e7893b6321openalex-snapshot
PBM/PDZ affinities quantification and their modulating sites by experimental and computational approaches
inferred← citeshttps://doi.org/10.7150/ijbs.102461openalex-snapshot
USP5 Binds and Stabilizes EphA2 to Increase Nasopharyngeal Carcinoma Radioresistance
inferred← citeshttps://doi.org/10.7150/ijbs.82567openalex-snapshot
Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
inferred← citeshttps://doi.org/10.7150/thno.22552openalex-snapshot
S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer
inferred← citeshttps://doi.org/10.7554/elife.36645openalex-snapshot
A novel pH-dependent membrane peptide that binds to EphA2 and inhibits cell migration
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.